CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Perrigo

perrigo

Perrigo To Transfer Common Stock Listing To NYSE

Perrigo Co. (Nasdaq: PRGO) Thursday announced that it is transferring the listing of its U.S. traded common stock to the New York Stock Exchange from the Nasdaq Global Select Market.

WWJ Newsradio 950–05/23/2013

Photo courtesy Michigan Humane Society.

Perrigo Closes Acquisition Of Pet Health Company Velcera

Perrigo Co. (Nasdaq: PRGO) Monday announced that it has closed the acquisition of Velcera Inc., the Yardley, Pa.-based pet health products company, for $160 million in cash.

WWJ Newsradio 950–04/01/2013

perrigo

Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%

Perrigo Co. (Nasdaq: PRGO) announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for testosterone gel 1.62 percent and that it has notified AbbVie Inc., the owner of the Reference Listed Drug of its filing.

WWJ Newsradio 950–02/19/2013

perrigo

Perrigo Buys British Pharma Firm For $283M

Perrigo Co., the Allegan-based over-the-counter health and beauty products and generic pharmaceutical maker, Monday announced a deal to acquire Leeds, England-based Rosemont Pharmaceuticals Ltd. for $283 million in cash.

WWJ Newsradio 950–02/11/2013

perrigo

Perrigo Confirms FDA Approval For Testosterone Gel 1%

Perrigo Company (Nasdaq: PRGO) announced that it has received U.S. Food and Drug Administration approval for its New Drug Application for testosterone gel 1%. Perrigo’s NDA included a bioequivalence study that compared its product to AbbVie’s AndroGel 1%.

WWJ Newsradio 950–02/06/2013

perrigo

Perrigo Reports Record Second Quarter Revenue, Higher Profit

The Allegan generic drugmaker Perrigo Co. Friday record revenue of $883 million for its second fiscal quarter ended Dec. 29, up from $838.2 million in the same quarter a year earlier. Net income for the quarter was $106 million or $1.12 a share, up from $99.7 million or $1.06 aa share in the same quarter a year earlier.

WWJ Newsradio 950–02/03/2013

perrigologo

Perrigo Announces Animal Health Acquisition, New Drug

Perrigo Co. Friday announced that it has signed an agreement to acquire Yardley, Pa.-based Velcera Inc. for $160 million in cash.

WWJ Newsradio 950–02/03/2013

perrigo

Perrigo Offers New Packaging For Infant Formula

Allegan’s Perrigo Co., the world’s largest makers of store brand infant formulas, Friday announced a new packaging look with new features.

WWJ Newsradio 950–01/27/2013

perrigo

Perrigo Confirms Settlement Of Generic Version Of Ofirmev Injection Patent Litigation

Allegan-based Perrigo Co. (Nasdaq: PRGO) announced that it has agreed to settle its Hatch-Waxman litigation relating to Ofirmev (acetaminophen) injection brought by Cadence Pharmaceuticals Inc.

WWJ Newsradio 950–11/28/2012

perrigo

Perrigo Announces FDA Final Approval Of Betamethasone Valerate Foam

Perrigo Co. (Nasdaq: PRGO) Tuesday announced that its partner, Cobrek Pharmaceuticals Inc., received final approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for betamethasone valerate foam 0.12 percent, the generic equivalent of Luxiq Foam.

WWJ Newsradio 950–11/27/2012

more

previous